Danny Motyka is the CEO of Psygen Industries Ltd., a licensed manufacturer of several restricted drugs including psilocybin, LSD, and MDMA. He has been a proponent of therapeutic and medicinal applications of psychedelics for more than 15 years. Danny believes that clinical and scientific research will demonstrate therapeutic utility and help to dispel the stigma associated with psychedelics.
